HEADER TRANSFERASE 14-AUG-12 4B6L TITLE DISCOVERY OF ORAL POLO-LIKE KINASE (PLK) INHIBITORS WITH ENHANCED TITLE 2 SELECTIVITY PROFILE USING RESIDUE TARGETED DRUG DESIGN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC KINASE DOMAIN, RESIDUES 52-332; COMPND 5 SYNONYM: POLO-LIKE KINASE 3, CYTOKINE-INDUCIBLE SERINE/THREONINE- COMPND 6 PROTEIN KINASE, FGF-INDUCIBLE KINASE, POLO-LIKE KINASE 3, PLK-3, COMPND 7 PROLIFERATION-RELATED KINASE; COMPND 8 EC: 2.7.11.21; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PBEV10TOPO KEYWDS TRANSFERASE, KINASE INHIBITORS, WATER-MEDIATED H-BOND EXPDTA X-RAY DIFFRACTION AUTHOR K.BROWN,J.D.CHARRIER,S.DURRANT,M.GRIFFITHS,C.HUDSON,D.KAY,R.KNEGTEL, AUTHOR 2 M.ODONNELL,F.PIERARD,H.TWIN,P.WEBER,S.YOUNG REVDAT 2 08-MAY-24 4B6L 1 REMARK REVDAT 1 21-AUG-13 4B6L 0 JRNL AUTH K.BROWN,J.D.CHARRIER,S.DURRANT,M.GRIFFITHS,C.HUDSON,D.KAY, JRNL AUTH 2 R.KNEGTEL,M.ODONNELL,F.PIERARD,H.TWIN,P.WEBER,S.YOUNG JRNL TITL DISCOVERY OF ORAL POLO-LIKE KINASE (PLK) INHIBITORS WITH JRNL TITL 2 ENHANCED SELECTIVITY PROFILE USING RESIDUE TARGETED DRUG JRNL TITL 3 DESIGN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 26307 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.247 REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1327 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.01 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2251 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.4764 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2156 REMARK 3 BIN R VALUE (WORKING SET) : 0.4713 REMARK 3 BIN FREE R VALUE : 0.5993 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 95 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2269 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 228 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.77 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.89850 REMARK 3 B22 (A**2) : -18.18370 REMARK 3 B33 (A**2) : 9.28520 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -9.62160 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.405 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.194 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.177 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.189 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.175 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.895 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.864 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2369 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3213 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 819 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 46 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 345 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2369 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 297 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3169 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.05 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.15 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 51.4489 1.9461 1.6916 REMARK 3 T TENSOR REMARK 3 T11: 0.0371 T22: -0.0684 REMARK 3 T33: -0.0707 T12: 0.0044 REMARK 3 T13: -0.0553 T23: 0.0076 REMARK 3 L TENSOR REMARK 3 L11: 1.4250 L22: 0.4024 REMARK 3 L33: 1.0174 L12: 0.2925 REMARK 3 L13: -0.1649 L23: -0.0846 REMARK 3 S TENSOR REMARK 3 S11: -0.0047 S12: -0.1055 S13: -0.0420 REMARK 3 S21: -0.0290 S22: 0.0150 S23: 0.0071 REMARK 3 S31: 0.0245 S32: 0.0355 S33: -0.0103 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 4B6L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1290053737. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.5 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27438 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 44.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 200 DATA REDUNDANCY : 1.600 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.40 REMARK 200 R MERGE FOR SHELL (I) : 0.69000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M NAH2PO4, 1.2M K2HPO4, 0.1M MES PH REMARK 280 5.2, 10MM DTT REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 72.07000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.18500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 72.07000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.18500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2115 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 56 -127.65 -90.82 REMARK 500 LYS A 70 -121.26 -119.33 REMARK 500 ARG A 115 -68.71 -29.69 REMARK 500 SER A 126 -64.88 -96.19 REMARK 500 LYS A 145 -128.97 59.12 REMARK 500 HIS A 155 -48.63 75.77 REMARK 500 ARG A 184 -5.63 74.35 REMARK 500 ASP A 203 88.67 59.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9ZP A 1333 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1334 DBREF 4B6L A 52 332 UNP Q9H4B4 PLK3_HUMAN 52 332 SEQRES 1 A 281 LEU ILE THR ASP PRO ARG SER GLY ARG THR TYR LEU LYS SEQRES 2 A 281 GLY ARG LEU LEU GLY LYS GLY GLY PHE ALA ARG CYS TYR SEQRES 3 A 281 GLU ALA THR ASP THR GLU THR GLY SER ALA TYR ALA VAL SEQRES 4 A 281 LYS VAL ILE PRO GLN SER ARG VAL ALA LYS PRO HIS GLN SEQRES 5 A 281 ARG GLU LYS ILE LEU ASN GLU ILE GLU LEU HIS ARG ASP SEQRES 6 A 281 LEU GLN HIS ARG HIS ILE VAL ARG PHE SER HIS HIS PHE SEQRES 7 A 281 GLU ASP ALA ASP ASN ILE TYR ILE PHE LEU GLU LEU CYS SEQRES 8 A 281 SER ARG LYS SER LEU ALA HIS ILE TRP LYS ALA ARG HIS SEQRES 9 A 281 THR LEU LEU GLU PRO GLU VAL ARG TYR TYR LEU ARG GLN SEQRES 10 A 281 ILE LEU SER GLY LEU LYS TYR LEU HIS GLN ARG GLY ILE SEQRES 11 A 281 LEU HIS ARG ASP LEU LYS LEU GLY ASN PHE PHE ILE THR SEQRES 12 A 281 GLU ASN MET GLU LEU LYS VAL GLY ASP PHE GLY LEU ALA SEQRES 13 A 281 ALA ARG LEU GLU PRO PRO GLU GLN ARG LYS LYS THR ILE SEQRES 14 A 281 CYS GLY THR PRO ASN TYR VAL ALA PRO GLU VAL LEU LEU SEQRES 15 A 281 ARG GLN GLY HIS GLY PRO GLU ALA ASP VAL TRP SER LEU SEQRES 16 A 281 GLY CYS VAL MET TYR THR LEU LEU CYS GLY SER PRO PRO SEQRES 17 A 281 PHE GLU THR ALA ASP LEU LYS GLU THR TYR ARG CYS ILE SEQRES 18 A 281 LYS GLN VAL HIS TYR THR LEU PRO ALA SER LEU SER LEU SEQRES 19 A 281 PRO ALA ARG GLN LEU LEU ALA ALA ILE LEU ARG ALA SER SEQRES 20 A 281 PRO ARG ASP ARG PRO SER ILE ASP GLN ILE LEU ARG HIS SEQRES 21 A 281 ASP PHE PHE THR LYS GLY TYR THR PRO ASP ARG LEU PRO SEQRES 22 A 281 ILE SER SER CYS VAL THR VAL PRO HET 9ZP A1333 35 HET SO4 A1334 5 HETNAM 9ZP 4-[[(4R)-5-CYCLOPENTYL-4-ETHYL-3A,4-DIHYDRO-3H-[1,2, HETNAM 2 9ZP 4]TRIAZOLO[4,3-F]PTERIDIN-7-YL]AMINO]-N-CYCLOPROPYL-3- HETNAM 3 9ZP METHOXY-BENZAMIDE HETNAM SO4 SULFATE ION FORMUL 2 9ZP C25 H32 N8 O2 FORMUL 3 SO4 O4 S 2- FORMUL 4 HOH *228(H2 O) HELIX 1 1 SER A 96 ALA A 99 5 4 HELIX 2 2 LYS A 100 ARG A 115 1 16 HELIX 3 3 SER A 146 HIS A 155 1 10 HELIX 4 4 LEU A 158 ARG A 179 1 22 HELIX 5 5 LYS A 187 GLY A 189 5 3 HELIX 6 6 ALA A 228 LEU A 233 1 6 HELIX 7 7 GLY A 238 GLY A 256 1 19 HELIX 8 8 ASP A 264 GLN A 274 1 11 HELIX 9 9 SER A 284 LEU A 295 1 12 HELIX 10 10 SER A 298 ARG A 302 5 5 HELIX 11 11 SER A 304 ARG A 310 1 7 HELIX 12 12 HIS A 311 LYS A 316 1 6 HELIX 13 13 PRO A 324 VAL A 329 5 6 SHEET 1 AA 6 ILE A 53 THR A 54 0 SHEET 2 AA 6 TYR A 62 GLY A 69 -1 O TYR A 62 N THR A 54 SHEET 3 AA 6 ARG A 75 ASP A 81 -1 O CYS A 76 N LEU A 68 SHEET 4 AA 6 ALA A 87 PRO A 94 -1 O TYR A 88 N ALA A 79 SHEET 5 AA 6 ASN A 134 LEU A 139 -1 O ILE A 135 N ILE A 93 SHEET 6 AA 6 PHE A 125 GLU A 130 -1 N SER A 126 O PHE A 138 SHEET 1 AB 2 ILE A 181 LEU A 182 0 SHEET 2 AB 2 ALA A 208 ARG A 209 -1 O ALA A 208 N LEU A 182 SHEET 1 AC 2 PHE A 191 ILE A 193 0 SHEET 2 AC 2 LEU A 199 VAL A 201 -1 O LYS A 200 N PHE A 192 CISPEP 1 GLY A 72 PHE A 73 0 3.33 SITE 1 AC1 16 ARG A 66 LEU A 67 LEU A 68 GLY A 69 SITE 2 AC1 16 CYS A 76 ALA A 89 LYS A 91 VAL A 123 SITE 3 AC1 16 LEU A 139 GLU A 140 LEU A 141 CYS A 142 SITE 4 AC1 16 LYS A 145 PHE A 192 HOH A2033 HOH A2152 SITE 1 AC2 8 ARG A 57 HIS A 177 VAL A 243 SER A 304 SITE 2 AC2 8 ILE A 305 HOH A2188 HOH A2219 HOH A2228 CRYST1 144.140 56.370 45.320 90.00 96.83 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006938 0.000000 0.000831 0.00000 SCALE2 0.000000 0.017740 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022223 0.00000